All of our Cord blood has been collected from placentas and umbilical cords after birth by specially trained nurses and technicians of the National Cord Blood Program (NCBP) and are provided without donor identifiers or donor-specific information. 

We have a large inventory of frozen Cord Blood Units (CBUs) available for research. These CBUs have been volume-reduced to remove most of the red blood cells and plasma and have been concentrated to 25 mL final volume, including the cryoprotectant. They are frozen with controlled-rate method and are stored in Liquid Nitrogen in BioArchive freezers. The frozen CBUs have had at least some testing performed including infectious disease markers, HLA, bacteriology, flow cytometry, and CBC.

Frozen CBUs with specific characteristics, e.g. total cell or CD34+ count, or HLA typing, can be provided upon request.

In February 2023, we celebrated the 30^th Anniversary of our program. NCBP is the world’s first and largest public cord blood bank; the first in the world to obtain a Biologics License from the FDA to manufacture HEMACORD®; and the first ever where clinical transplants of unrelated donor cord blood were performed using NCBP cord blood units.

For three decades, NCBP has ensured that lifesaving cord blood units are available for patients with leukemia, lymphoma, severe aplastic anemia, and other lethal diseases of the blood or immune system.

We provide complex enrichment and/or depletion procedures using monoclonal antibodies, magnetic particles, and flow cytometric cell sorting. Fresh or cryopreserved purified cells are offered in aliquots of:

• 0.1 million cells per vial
• 0.5 million cells per vial
• 1 million cells per vial
• 5 million cells per vial

CD34+ hematopoietic stem and progenitor cells are highly purified and viable cells isolated from cord blood or peripheral blood.

CCS provides additional specialty blood products for research use only:

• Antibody-Positive Donor Plasma
• Monoclonal Antibodies to RBC Antigens